-
December 1: The Week in Cancer NewsFDA announces investigation into CAR T-cell therapy, and precision therapies are not available for most cancer diagnoses.
by Kevin McLaughlin
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
November 17: The Week in Cancer NewsStudy finds association between vitamin D levels and risk for peripheral neuropathy, and new report highlights rising lung cancer survival.
by Thomas Celona
-
Progress in Lung CancerNovember is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
-
November 10: The Week in Cancer NewsSun exposure is an occupational hazard around the globe, and a dormant virus can cause immunotherapy complications.
by Eric Fitzsimmons
-
Against All OddsAt age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren
-
November 3: The Week in Cancer NewsRecommendation suggests ongoing lung cancer screening for those with heavy smoking history even after quitting, and children with Down syndrome and leukemia face worse outcomes.
by Marci A. Landsmann
-
Finding the ‘Silent Killer’Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.
by Eve Spiegel
-
October 27: The Week in Cancer NewsLiving alone may increase the risk of cancer death, and cervical cancer study results called ‘remarkable.’
by Kevin McLaughlin
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
